Ortin Laboratories Ltd.

Name: Ortin Laboratories Ltd. Share Price Today, Stock Analysis
Brand: Ortin Laboratories Ltd.

Stock Card

NSE: ORTINGLOBE | BSE: 539287

₹15.69

₹-0.05 (-0.32%)

As on 03-Jun-2026IST

Market cap

₹12 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

P/B Ratio

9.9

Div. Yield

0 %

Ortin Laboratories Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 14.96 High: 16.52

52 Week Range

Low: 10.59 High: 19.90

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

₹-1 Cr
ROE

-35.3 %
ROCE

-24.4 %
Industry P/E

45.04
EV/EBITDA

-17.6
Debt to Equity

0.1
Book Value

₹1.5
EPS

₹-1.1
Face value

10
Shares outstanding

8,131,392

10 Years Aggregate

CFO

₹28.57 Cr

EBITDA

₹23.29 Cr

Net Profit

₹-5.70 Cr

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Ortin Laboratories	13.6	1.2	-4.2	40.8	-6.8	-10.6	-0.8
BSE Healthcare	7.1	4.2	6.3	9.1	24.6	13.5	11.9

As on 03-Jun-2026

Company	2025	2024	2023	2022	2021	2020	2019
Ortin Laboratories	-22.7	-21.8	-2.7	-28.7	-46.1	200.5	-35.1
BSE Small Cap	-6.6	29.0	47.5	-1.8	62.8	32.1	-6.8
BSE Healthcare	-3.3	43.1	37.0	-12.1	20.9	61.4	-3.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price (₹)	Market Cap (₹ Cr)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Ortin Laboratories	15.7	12.3	0.2	-0.9	-452.8	-54.5	--	9.9
Acutaas Chemicals	3,135.7	25,659.6	1,339.4	356.4	33.2	23.2	72	15.5
Cohance Lifesciences	424.8	16,247.6	2,268.6	150.1	10.6	5.4	90.7	4.2
Granules India	793.8	19,649.1	5,365.6	595.0	16.6	13.3	33	3.9
Jubilant Pharmova	978.9	15,619.1	8,279.6	397.8	9.9	6.4	39.2	2.2
Natco Pharma	934.5	16,761.1	4,078.3	1,371.9	30.2	15.9	11.8	1.8
Onesource Specialty Pharma	1,810.5	20,740.0	1,421.6	-73.8	1.8	-1.1	--	3.6
Piramal Pharma	167.0	22,211.7	8,869.1	-383.1	1.0	-4.2	--	2.7
Syngene Intl	438.1	17,704.9	3,738.7	316.7	12.5	7.5	55.9	3.7
Wockhardt	2,073.9	33,781.3	3,373.0	199.0	12.6	5.9	158.6	6.8

Shareholding Pattern

View Details

News & Analysis

All News

No Review & Analysis are available.

About Ortin Laboratories

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as... anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulcerants, anti-spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti-retroviral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti-ulcerants, and anti-malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development, and assay development; research and development services for new formulation brands; and diagnostic services comprising development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; operates as a merchant exporter of pharmaceutical finished formulations; and engages in real estate. The company was formerly known as Ortin Laboratories Limited and changed its name to Ortin Global Limited in June 2024. Ortin Global Limited was incorporated in 1986 and is headquartered in Hyderabad, India. Read more